(Q30714513)

26 June 2017

1 reference

1 reference

title

beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review (English)

1 reference

26 June 2017

1 reference

1 reference

prostatic hypertrophy

1 reference

Wilt TJ

1

1 reference

26 June 2017

MacDonald R

series ordinal

2

1 reference

26 June 2017

Ishani A

series ordinal

3

1 reference

26 June 2017

publication date

1 June 1999

1 reference

26 June 2017

1 reference

26 June 2017

volume

83

1 reference

26 June 2017

issue

9

1 reference

26 June 2017

page(s)

976-983

1 reference

Benign Prostatic Hyperplasia: Antecedents and Natural History

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00026.X

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00026.X

Harmless herbs? A review of the recent literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00026.X

Benign prostatic hyperplasia. Medical and minimally invasive treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00026.X

Phytotherapy in treatment of benign prostatic hyperplasia: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00026.X

Survey of intensive care of severely head injured patients in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00026.X

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00026.X

Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00026.X

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00026.X

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00026.X

10.1046/J.1464-410X.1999.00026.X

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference